Incyte
Stock Forecast, Prediction & Price Target

Incyte (INCY) stock Price Target by analysts

Last Year
Average Price Target

$95.63

Potential upside: 11.89%

Based on 7 analysts

Incyte price prediction

Strike.market

What is Incyte stock analysts` prediction?

Incyte stock forecast: Based on 7 Wall Street analysts` predicted price targets for Incyte in the last 3 months, the avarage price target is $95.63, with a high forecast of $NaN. The average price target represents a 11.89% change from the last price of $85.46.

Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.

Incyte stock Price Target by analysts

Full breakdown of analysts given Incyte price targets

Analyst name & company
Analyst win rate
Publish date
Price target
Price when posted
Source Historical targets
David Lebowitz
Citigroup
0%
0/2
10 months ago $97 13.50% upside $73.6 StreetInsider
Previous targets (1)
Jay Olson
Oppenheimer
0%
0/4
10 months ago $82 -4.04% downside $73.6 TheFly
Previous targets (3)
Aaron Kessler
Seaport Global
0%
0/1
10 months ago $200 134.02% upside $73 Benzinga
Previous targets (0)
Kelly Shi
Jefferies
0%
0/1
10 months ago $84 -1.70% downside $73.6 StreetInsider
Previous targets (0)
Tazeen Ahmad
Bank of America Securities
0%
0/2
10 months ago $90 5.31% upside $73.6 StreetInsider
Previous targets (1)
Andy Chen
Wolfe Research
0%
0/1
11 months ago $84 -1.70% downside $66.1 TheFly
Previous targets (0)
Tazeen Ahmad
Bank of America Securities
0%
0/2
12 months ago $68 -20.43% downside $63.56 StreetInsider
Previous targets (1)
Salveen Richter
Goldman Sachs
0%
0/2
12 months ago $60 -29.79% downside $63.56 StreetInsider
Previous targets (1)
David Lebowitz
Citigroup
0%
0/2
about 1 year ago $92 7.65% upside $62.16 TheFly
Previous targets (1)
Brian Abrahams
RBC Capital
0%
0/1
about 1 year ago $66 -22.77% downside $65.7 TheFly
Previous targets (0)
Jay Olson
Oppenheimer
0%
0/4
about 1 year ago $81 -5.21% downside $68.57 TheFly
Previous targets (3)
Evan Seigerman
BMO Capital
50%
1/2
about 1 year ago $48 -43.83% downside $60.87 StreetInsider
Previous targets (1)
James Shin
Deutsche Bank
0%
0/1
over 1 year ago $55 -35.64% downside $58.2 TheFly
Previous targets (0)
Evan David Seigerman
BMO Capital
100%
1/1
over 1 year ago $52 -39.15% downside $52.05 StreetInsider
Previous targets (0)
Jasper Hellweg
Argus Research
0%
0/1
over 1 year ago $70 -18.09% downside $50.48 TheFly
Previous targets (0)
Unknown
Cowen & Co.
N/A
over 2 years ago $100 17.01% upside $80.38 Benzinga
N/A
Unknown
Wells Fargo
N/A
over 2 years ago $75 -12.23% downside $79.74 Benzinga
N/A
Jay Olson
Oppenheimer
0%
0/4
about 3 years ago $98 14.67% upside $73.99 Pulse 2.0
Previous targets (3)
Unknown
Leerink Partners
N/A
about 3 years ago $63 -26.28% downside $81.36 Benzinga
N/A
Unknown
Morgan Stanley
N/A
over 3 years ago $76 -11.06% downside $78.94 Benzinga
N/A
Evan Seigerman
BMO Capital
50%
1/2
over 3 years ago $75 -12.23% downside $70.07 StreetInsider
Previous targets (1)
Michael Schmidt
Guggenheim
0%
0/1
over 3 years ago $104 21.69% upside $73.97 TheFly
Previous targets (0)
Salveen Richter
Goldman Sachs
0%
0/2
almost 4 years ago $136 59.13% upside $66.74 StreetInsider
Previous targets (1)
Jay Olson
Oppenheimer
0%
0/4
almost 4 years ago $109 27.54% upside $66.79 StreetInsider
Previous targets (3)
Alethia Young
Cantor Fitzgerald
100%
1/1
almost 4 years ago $79 -7.55% downside $65.56 TheFly
Previous targets (0)
Aydin Huseynov
Ladenburg Thalmann & Co.
0%
0/1
almost 4 years ago $89 4.14% upside $69.78 TheFly
Previous targets (0)

Incyte Financial Estimates

Incyte Revenue Estimates

Incyte EBITDA Estimates

Incyte Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$2.98B
 
N/A
$3.39B
 
13.67%
$3.69B
 
8.86%
Avg: $4.51B
Low: $4.43B
High: $4.74B
avg. 22.18%
Avg: $5.00B
Low: $4.78B
High: $5.22B
avg. 10.75%
Avg: $5.35B
Low: $5.12B
High: $5.59B
avg. 7.08%
Avg: $5.58B
Low: $5.34B
High: $5.83B
avg. 4.24%
Net Income
 
% change YoY
$948.58M
 
N/A
$340.66M
 
-64.08%
$597.59M
 
75.42%
Avg: $955.27M
Low: $700.37M
High: $1.33B
avg. 59.85%
Avg: $1.21B
Low: $858.52M
High: $1.59B
avg. 26.72%
Avg: $1.61B
Low: $1.52B
High: $1.71B
avg. 33.53%
Avg: $1.81B
Low: $1.71B
High: $1.92B
avg. 12.42%
EBITDA
 
% change YoY
$611.16M
 
N/A
$631.52M
 
3.33%
$919.42M
 
45.58%
Avg: $698.63M
Low: $686.34M
High: $733.94M
avg. -24.01%
Avg: $773.77M
Low: $740.23M
High: $808.89M
avg. 10.75%
Avg: $828.59M
Low: $792.67M
High: $866.19M
avg. 7.08%
Avg: $863.80M
Low: $826.35M
High: $903.00M
avg. 4.24%
EPS
 
% change YoY
$4.3
 
N/A
$1.53
 
-64.41%
$2.67
 
74.50%
Avg: $4.17
Low: $3.1
High: $5.9
avg. 56.28%
Avg: $5.29
Low: $3.8
High: $7.06
avg. 26.72%
Avg: $7.15
Low: $6.75
High: $7.58
avg. 35.30%
Avg: $8.04
Low: $7.59
High: $8.52
avg. 12.42%
Operating Expenses
 
% change YoY
$2.23B
 
N/A
$2.59B
 
16.16%
$2.82B
 
8.63%
Avg: $1.14B
Low: $1.12B
High: $1.20B
avg. -59.39%
Avg: $1.26B
Low: $1.21B
High: $1.32B
avg. 10.75%
Avg: $1.35B
Low: $1.29B
High: $1.41B
avg. 7.08%
Avg: $1.41B
Low: $1.35B
High: $1.48B
avg. 4.24%

FAQ

What is Incyte stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 33.13% in 2025-2028.

We have gathered data from 12 analysts. Their low estimate is 700.37M, average is 955.27M and high is 1.33B.

What is Incyte stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 11.06% in 2025-2028.

We have gathered data from 17 analysts. Their low revenue estimate is $4.43B, average is $4.51B and high is $4.74B.

What is Incyte stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 32.68% in 2025-2028.

We have gathered data from 12 analysts. Their low earnings per share estimate is $3.1, average is $4.17 and high is $5.9.

What is the best performing analyst?

In the last twelve months 7 analysts have been covering Incyte stock. The most successful analyst is David Lebowitz.